Valid for Submission
T52.4X3D is a billable diagnosis code used to specify a medical diagnosis of toxic effect of ketones, assault, subsequent encounter. The code T52.4X3D is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
T52.4X3D is a subsequent encounter code, includes a 7th character and should be used after the patient has completed active treatment for a condition like toxic effect of ketones assault. According to ICD-10-CM Guidelines a "subsequent encounter" occurs when the patient is receiving routine care for the condition during the healing or recovery phase of treatment. Subsequent diagnosis codes are appropriate during the recovery phase, no matter how many times the patient has seen the provider for this condition. If the provider needs to adjust the patient's care plan due to a setback or other complication, the encounter becomes active again.
Diagnostic Related Groups - MS-DRG Mapping
Present on Admission (POA)
Convert T52.4X3D to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code T52.4X3D its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.